NCT04846712 Interest of Ultrasound in the Diagnosis of Severity of Lateral Ankle Sprain
| NCT ID | NCT04846712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Ankle Sprains |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2021-12-01 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ankle sprain is a frequent and widely trivialized trauma. Misdiagnosed or poorly treated, it can recur and thus develop into chronic ankle instability. It can be associated with complications which, if not detected early, can lead to long-term sequelae.
Eligibility Criteria
Inclusion Criteria: * First ankle sprain with sport or work disability Exclusion Criteria: * Patient with fractures, dislocation or hyperlaxity * Previous ankle sprain
Contact & Investigator
Thomas NERI, MD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT04846712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Ankle Sprains. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04846712 currently recruiting?
Yes, NCT04846712 is actively recruiting participants. Contact the research team at thomas.neri@chu-st-etienne.fr for enrollment information.
Where is the NCT04846712 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT04846712 clinical trial?
NCT04846712 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Thomas NERI, MD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 50 participants.